共 34 条
- [21] Comparative intra-articular gene transfer of seven adeno-associated virus serotypes reveals that AAV2 mediates the most efficient transduction to mouse arthritic chondrocytesPLOS ONE, 2020, 15 (12):Chen, QuanLuo, HuanZhou, ChengcongYu, HuanYao, SaiFu, FangdaSeeley, RebeccaJi, XingYang, YanpingChen, PeifengJin, HongtingTong, PeijianChen, DiWu, ChengliangDu, WeibinRuan, Hongfeng
- [22] Pre-existing immunity to adeno-associated virus (AAV)2 limits transgene expression following intracerebral AAV2-based gene delivery in a 6-hydroxydopamine model of Parkinson's diseaseJOURNAL OF GENE MEDICINE, 2014, 16 (9-10): : 300 - 308Janelidze, ShorenaNordstrom, UlrikaKugler, SebastianBrundin, Patrik
- [23] Imaging of AAV2-hAADC Delivery in a Phase I Study of AAV2-hAADC Gene Therapy for Parkinson's DiseaseMOLECULAR THERAPY, 2009, 17 : S194 - S194Bankiewicz, Krystof S.Valles, FranciscoStarr, Philip A.Larson, PaulChristine, Chadwick W.Fiandaca, Massimo S.Forsayeth, JohnEberling, Jamie L.Aminoff, Michael J.
- [24] A phase I trial of adeno-associated virus serotype 1-γ-sarcoglycan gene therapy for limb girdle muscular dystrophy type 2CBRAIN, 2012, 135 : 483 - 492Herson, SergeHentati, FaycalRigolet, AudeBehin, AnthonyRomero, Norma B.Leturcq, FranceLaforet, PascalMaisonobe, ThierryAmouri, RimHaddad, HafedhAudit, MurielMontus, MarieMasurier, CaroleGjata, BernardGeorger, ChristopheCherai, MustaphaCarlier, PierreHogrel, Jean-YvesHerson, ArianeAllenbach, YvesLemoine, Francois M.Klatzmann, DavidSweeney, H. LeeMulligan, Richard C.Eymard, BrunoCaizergues, DidierVoit, ThomasBenveniste, Olivier
- [25] A Phase 1/2 open-label trial of an adeno-associated virus (AAV) serotype 8 factor IX gene therapy (AskBio009) in adults with hemophilia BHAEMOPHILIA, 2013, 19 (03) : 468 - 469Monahan, P. E.Walsh, C.Powell, J.Gomperts, E.Samulski, R. JudeMcphee, S.
- [26] Characterization of intrastriatal recombinant adeno-associated virus-mediated gene transfer of human tyrosine hydroxylase and human GTP-cyclohydrolase I in a rat model of Parkinson's diseaseJOURNAL OF NEUROSCIENCE, 1998, 18 (11): : 4271 - 4284Mandel, RJRendahl, KGSpratt, SKSnyder, ROCohen, LKLeff, SE
- [27] Phase I trial of intranasal and endobronchial administration of a recombinant adeno-associated virus serotype 2 (rAAV2)-CFTR vector in adult cystic fibrosis patients: A two-part clinical studyHUMAN GENE THERAPY, 2003, 14 (11) : 1079 - 1088Flotte, TRZeitlin, PLReynolds, TCHeald, AEPedersen, PBeck, SConrad, CKBrass-Ernst, LHumphries, MSullivan, KWetzel, RTaylor, GCarter, BJGuggino, WB
- [28] Phase I/II Study of Intrapleural Administration of a Serotype rh.10 Replication-Deficient Adeno-Associated Virus Gene Transfer Vector Expressing the Human α1-Antitrypsin cDNA to Individuals with α1-Antitrypsin DeficiencyHUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2014, 25 (03) : 112 - 133Chiuchiolo, Maria J.Kaminsky, Stephen M.Sondhi, DolanMancenido, DenesyHollmann, CharleenCrystal, Ronald G.
- [29] Danon Disease Phase 1 RP-A501 Results: The First Single-Dose Intravenous Gene Therapy with Recombinant Adeno-Associated Virus (AAV9:LAMP2B) for a Monogenic CardiomyopathyCIRCULATION, 2024, 150 (25) : E739 - E739Greenberg, BarryTaylor, MatthewColan, StevenAdler, EricRicks, DavidYarabe, PaulBattiprolu, PavanShah, GuaravPatel, KinnariCoggins, MatthewSchwartz, JonathanRossano, Joseph
- [30] Phase 1 Danon Disease Results: The First Single Dose Intravenous (IV) Gene Therapy (RP-A501) With Recombinant Adeno-Associated Virus (AAV9:LAMP2B) for a Monogenic CardiomyopathyCIRCULATION, 2022, 146Rossano, JosephTaylor, MatthewLin, KimberlyEpstein, ShilpiBattiprolu, PavanRicks, DavidWaldron, AbigailSchwartz, JonathanGreenberg, Barry